TrialOpen heart2025

Changes in frailty based on minimally important difference and the impact of spironolactone on frailty in heart failure with preserved ejection fraction: insights from the TOPCAT trial.

Yangyang Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.